Cardima Revelation Tx system
This article was originally published in The Gray Sheet
Executive Summary
FDA's Circulatory System Devices Panel will review minimally invasive, linear ablation microcatheter system to treat atrial fibrillation May 29. Cardima is the only firm that has completed a multi-center trial and submitted a PMA for an AF-treating device, the firm claims March 6. Separately, FDA sends a letter to Cardima certifying compliance of its manufacturing facility after a recent inspection, the firm reports...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.